Across TCGA pan-cancer cohorts, KLF4 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated KLF4 data layer compared with 23 for mass-spec protein and 7 for mutation status.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher KLF4 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated KLF4 expression acts as an unfavorable survival marker, although some lineages such as HNSC and UCEC show a favorable association.
HNSC, UCEC, and LUAD are the cancer types where KLF4 mass-spec protein most reproducibly stratifies survival.